Yield Growth Corp. (CSE:BOSS) (OTCQB: BOSQF) (FSE: YG3) is pleased to announce that its wholly owned subsidiary, Urban Juve, now has 11 products available for international purchase through the urbanjuve.com site. Sales of Urban Juve products have now been completed to online purchasers in North America, Europe and Asia.

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/45272_web_uj-ecomm2.jpg


Figure 1

To view an enhanced version of Figure 1, please visit:
https://orders.newsfilecorp.com/files/6377/45272_Web_UJ-ecomm.jpg

Urban Juve is now available to purchasers in the largest skin care markets in the world, including China, the U.S., Japan, South Korea and Germany. Statista estimates the global skin care market to be worth US$134.5 billion in 2018, with this number expected to grow to US$180 billion by 2024. Also, according to Statista, the global natural and organic beauty market has been growing rapidly over the past few years and is expected to reach a value of about 22 billion U.S. dollars by 2024. Within the natural and organic beauty product market, the skin care segment holds the highest share of the market. In 2016, 57 percent of U.S. women said it was important to buy all-natural skin-care products.

Urban Juve products contain only the highest quality natural ingredients including full spectrum essential oils and pure botanical extracts, with legal, high quality hemp derivatives. Its products are cruelty free and contain no sulfates, parabens, artificial fragrances or dyes. Urban Juve’s key ingredient, cannabis sativa root extract, is made by Urban Juve in Canada using its proprietary patent pending extraction technology.

Urban Juve is supporting its international expansion through a targeted digital kiosk marketing campaign in high traffic shopping malls in Hong Kong, along with a social media influencer and video campaign in China. This month, it is also launching a digital media marketing program targeting residents in New York, Los Angeles, San Francisco, Vancouver, Calgary and Toronto. Urban Juve is currently finalizing packaging designed for expansion into the European retail market and will soon be looking to align with a European distributor.

About The Yield Growth Corp.

The Yield Growth Corp. is disrupting the $4.2 trillion-dollar global wellness market, by connecting ancient healing with modern science, and harnessing the power of hemp- and cannabis-infused products serving mainstream luxury consumers. The Yield Growth management team has deep experience with global brands including Johnson & Johnson, Procter & Gamble, M·A·C Cosmetics, Skechers, Best Buy, Aritzia, Coca-Cola and Pepsi Corporation. Its consumer brand, Urban Juve, signed over 110 retail locations to sell its products in North America and is launching e-commerce sales in China through WeChat. It has signed a sales and marketing alliance with ipsy, the world’s largest online beauty community, according to ipsy.

Key ingredients in all of Yield Growth’s branded products include cannabis sativa root extract, created using Urban Juve’s proprietary, patent-pending extraction technology. Urban Juve has filed 12 patent applications in the United States. Through its subsidiaries, Yield Growth has developed over 200 beauty and wellness cannabis formulas for commercialization and has multiple revenue streams including licensing, services and product sales.

For more information about Yield Growth, visit www.yieldgrowth.com or follow @yieldgrowth on Instagram. Visitwww.urbanjuve.com and #findyourjuve across social platforms to learn, engage and shop.

Investor Relations Contacts:

Penny Green, President & CEO
Kristina Pillon, Investor Relations
invest@yieldgrowth.com

1-833-514-BOSS 1-833-514-2677
1-833-515-BOSS 1-833-515-2677

The Canadian Securities Exchange has not reviewed, approved or disapproved the content of this news release.

Cautionary Statement Regarding Forward-Looking Statements

This press release includes forward-looking information and statements (collectively, “forward looking statements”) under applicable Canadian securities legislation. Forward-looking statements are necessarily based upon a number of estimates, forecasts, beliefs and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such risks, uncertainties and factors include, but are not limited to: risks related to the development, testing, licensing, intellectual property protection, and sale of, and demand for, Urban Juve, Wright & Well and UJ Beverages products, general business, economic, competitive, political and social uncertainties, delay or failure to receive board or regulatory approvals where applicable, and the state of the capital markets. Yield Growth cautions readers not to place undue reliance on forward-looking statements provided by Yield Growth, as such forward-looking statements are not a guarantee of future results or performance and actual results may differ materially. The forward-looking statements contained in this press release are made as of the date of this press release, and Yield Growth expressly disclaims any obligation to update or alter statements containing any forward-looking information, or the factors or assumptions underlying them, whether as a result of new information, future events or otherwise, except as required by law.

infoClick here to connect with Yield Growth Corp. (CSE:BOSS) for an Investor Presentation. 

Source: www.newsfilecorp.com

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”), of the important December 1, 2020 lead plaintiff deadline in the securities class action. The lawsuit seeks to recover damages for Aurora investors under the federal securities laws.

To join the Aurora class action, go to http://www.rosenlegal.com/cases-register-1965.html or call Phillip Kim, Esq. toll-free at 866-767-3653 or email pkim@rosenlegal.com or cases@rosenlegal.com for information on the class action.

Keep reading... Show less

Trading resumes in:

Company: 4Front Ventures Corp.

Keep reading... Show less

/NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES /

  4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) is pleased to announce that it has completed its previously announced bought deal prospectus offering (the ” Offering “) of units of the Company (” Units “), for aggregate gross proceeds of C$17,251,150 including full exercise of the over-allotment option granted to the underwriters in connection therewith.

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Tactile Systems Technology (NASDAQ:TCMD)
Class Period:
May 7, 2018 – June 8, 2020
Deadline: November 30, 2020
For more info: www.bgandg.com/tcmd

Keep reading... Show less

Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), announced today that it has re-filed its unaudited condensed interim consolidated financial statements, together with the notes thereto, for the three and six months ended June 30, 2020 and 2019 (the “ Interim Financial Statements ”) to correct, among other things, certain 2019 comparative period information and to update certain presentation arising from the Company’s early adoption of IFRS 3 in late 2019, which changes were identified in connection with the Company’s review engagement with its auditor. The Company does not consider these adjustments either individually nor in the aggregate, to be material.

The re-filed Interim Financial Statements reflect changes to the Condensed Interim Consolidated Statements of Loss and Comprehensive Loss comparative period to remove transaction fees from the income statement and capitalize them to the applicable acquisition in accordance with the Company’s early adoption of the amended IFRS 3 as set out in Note 2, and to reclassify $1 million from general and administrative expenses to transaction fees for presentation purposes to conform with the Company’s presentation used in its audited consolidated financial statements for the years ended December 31, 2019 and 2018 (the “ Audited Annual Financial Statements ”). The re-filed interim Financial Statements also reflect changes to the Condensed Interim Consolidated Statement of Changes in Shareholders’ Equity to correct the 2019 comparative period balances as they incorrectly reflect Q1 2019 period balances, update certain presentation to conform with the Company’s presentation used in its Audited Annual Financial Statements; and reduce the valuation conclusion of the Company’s acquisition of NettaGrowth International Inc. to conform with the Audited Annual Financial Statements. The re-filed Interim Financial Statements also bring forward the subsequent event note disclosure.

Keep reading... Show less